<DOC>
	<DOCNO>NCT02889224</DOCNO>
	<brief_summary>Working hypothesis : interaction endogenous endocannabinoïds ( ECS ) - cortisol , end product Hypothalamo-Pituitary-Adrenal ( HPA ) axis may play role pathophysiology Cushing 's syndrome . The investigator speculate : - acute chronic variation plasma cortisol may induce change activity ECS - circadian rhythm ECS driven rythm plasma cortisol</brief_summary>
	<brief_title>In Vivo Study Interactions Between Endocannabinoid System Corticotropic Axis Man</brief_title>
	<detailed_description>The study aim identify relationship ECS HPA axis human main objective ass Cushing 's syndrome induces change ECS activity . For purpose : 1. investigors compare plasma level ECS obese control patient Cushing 's syndrome 2. investigors compare plasma level ECS patient Cushing 's syndrome immediately curative surgery 3. investigors compare plasma level ECS patient hypoadrenalism intake substitutive dos hydrocortisone 4. investigors evaluate plasma level ECS short synacthen test healthy subject .</detailed_description>
	<mesh_term>Cushing Syndrome</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>For patient group : Age ≥ 18 , Social security. `` Hypercortisolism `` group : 18 &lt; BMI &lt; 40 kg/m2 , Cushing 's syndrome front : impaired 1 mg dexamethasone test ( 08:00 A.M. cortisol &gt; 50 nmol/L ) qualitative quantitative disrupt circadian rhythm cortisol increase plasma concentration free urinary cortisol upper normal range ( 90 µg/24H ) , Hypercortisolism treat surgery ( adrenal adenoma treat adrenalectomy Cushing disease treat pituitary surgery ) . `` Obese `` group : Obese patient : 30 &lt; BMI &lt; 40 kg/m2 , Normal HPA axis function : 08:00 A.M. cortisol &gt; 250 nmol/L peak 550 nmol/L 1 mg SST , Normal 24H free urinary cortisol dexamethasone test. `` Control `` group : Lean overweight patient ( 18 &lt; BMI &lt; 30 kg/m2 ) , Non cortisol secrete pituitary adrenal tumor , Patient biological evaluation HPA axis recommended. `` Hydrocortisone `` group : Lean overweight patient ( 18 &lt; BMI &lt; 30 kg/m2 ) , Primary secondary adrenal insufficiency , With need hydrocortisone supplementation . Patients eat disorder , major depressive disorder psychiatric disorder Cushing 's syndrome , Cannabis consumption , alcoholism drug addiction , Active smoking , cortisone treatment hydrocortisone , Pregnancy feeding , Surgery obesity , Incapability , Pathology lifethreatening short term , Any situation interfere study risked patient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Cortisol</keyword>
	<keyword>Hydrocortisone</keyword>
	<keyword>Endocannabinoïds</keyword>
</DOC>